Keenova Therapeutics plc Operating Lease, Payments
Keenova Therapeutics plc reported Operating Lease, Payments of $13.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-04-15
- Keenova Therapeutics plc operating lease, payments for the quarter ending 2019-12-27 was $6.10M.
- Keenova Therapeutics plc operating lease, payments for the quarter ending 2019-09-27 was $5.80M.
- Keenova Therapeutics plc operating lease, payments for the quarter ending 2019-06-28 was $5.80M.
- Keenova Therapeutics plc operating lease, payments for the quarter ending 2019-03-29 was $5.50M.
- Keenova Therapeutics plc operating lease, payments for fiscal 2025 was $13.50M, a 48.35% increase from fiscal 2024.
- Keenova Therapeutics plc operating lease, payments for fiscal 2024 was $9.10M.
- Keenova Therapeutics plc operating lease, payments for fiscal 2021 was $20.40M, a 11.69% decline from fiscal 2020.
- Keenova Therapeutics plc operating lease, payments for fiscal 2020 was $23.10M, a 0.43% decline from fiscal 2019.
| Period end | Operating Lease, Payments 1 month | Operating Lease, Payments 1 month as first filed | Operating Lease, Payments 3 month | Operating Lease, Payments 5 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 10 month | Operating Lease, Payments 10 month as first filed | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $13.50M 10-K · filed 2026-04-15 | |||||||||
| 2024-12-27 | $9.10M 10-K · filed 2026-04-15 | $13.80M 10-K · filed 2025-03-13 | ||||||||
| 2023-12-29 | $1.80M 10-K · filed 2026-04-15 | $2.40M 10-K · filed 2024-03-26 | ||||||||
| 2023-11-14 | $9.20M 10-K · filed 2026-04-15 | $14.60M 10-K · filed 2024-03-26 | ||||||||
| 2022-12-30 | $9.20M 10-K · filed 2025-03-13 | |||||||||
| 2022-06-16 | $9.40M 10-K · filed 2025-03-13 | |||||||||
| 2021-12-31 | $20.40M 10-K · filed 2024-03-26 | |||||||||
| 2020-12-25 | $23.10M 10-K · filed 2023-03-03 | |||||||||
| 2019-12-27 | $6.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $11.90M derived: sum of 2 quarters · filed 2022-03-15 | $17.70M derived: sum of 3 quarters · filed 2022-03-15 | $23.20M 10-K · filed 2022-03-15 | ||||||
| 2019-09-27 | $5.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $11.60M derived: sum of 2 quarters · filed 2019-11-05 | $17.10M 10-Q · filed 2019-11-05 | |||||||
| 2019-06-28 | $5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $11.30M 10-Q · filed 2019-08-06 | ||||||||
| 2019-03-29 | $5.50M 10-Q · filed 2019-05-07 |